Aminobenzoic acids and derivatives
Tolfenamic acid, 99+%
CAS: 13710-19-5 Molecular Formula: C14H12ClNO2 Molecular Weight (g/mol): 261.705 MDL Number: MFCD00133865 InChI Key: YEZNLOUZAIOMLT-UHFFFAOYSA-N Synonym: tolfenamic acid,clotam,n-3-chloro-2-methylphenyl anthranilic acid,2-3-chloro-2-methylphenyl amino benzoic acid,tolfedine,acido tolfenamico,acide tolfenamique,acidum tolfenamicum,tolfine,n-2-methyl-3-chlorophenyl anthranilic acid PubChem CID: 610479 ChEBI: CHEBI:32243 IUPAC Name: 2-(3-chloro-2-methylanilino)benzoic acid SMILES: CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O
Medchemexpress LLC Atractyloside potassium salt | 102130-43-8 | 802.99 | 1 ML
Atractyloside potassium salt is a powerful and specific inhibitor of mitochondrial ADP/ATP transport. It inhibits chloride channels from mitochondrial membranes of rat heart, activates autophagy, inhibits ANT2, mTOR, and promotes the activation of p-AMPK. This compound exhibits anti-cancer effects on non-small cell lung cancer and can inhibit liver steatosis. However, it also has nephrotoxicity.
- Powerful and specific inhibitor of mitochondrial ADP/ATP transport.
- Inhibits chloride channels from mitochondrial membranes of rat heart.
- Activates autophagy, inhibits ANT2, mTOR, and promotes the activation of p-AMPK.
- Exhibits anti-cancer effects on non-small cell lung cancer.
- Can inhibit liver steatosis.
- Purity: 99.93%.
Medchemexpress LLC 4-Aminobenzoic acid potassium | 138-84-1 | 99.96% | 500 MG
4-Aminobenzoic acid potassium (PABA) is a modifier of catecholamine oxidation reactions. It is promising for research of Parkinson's disease and hypertension.
- Promising for research of Parkinson's disease
- Promising for research of hypertension
- Used for research purposes only
Medchemexpress LLC 4-Aminobenzoic acid potassium | 138-84-1 | 99.8% | 50 G
4-Aminobenzoic acid (PABA) potassium is a modifier of catecholamine oxidation reactions. It shows promise for research related to Parkinson's disease and hypertension.
- Modifies catecholamine oxidation reactions.
- Promising for research of Parkinson's disease.
- Promising for research of hypertension.
Medchemexpress LLC 4-Aminobenzoic acid potassium | 138-84-1 | 99.75% | 10 G
4-Aminobenzoic acid potassium is a modifier of catecholamine oxidation reactions. It is promising for research related to Parkinson's disease and hypertension. It is intended for research use only.
- Modifier of catecholamine oxidation reactions
- Promising for research related to Parkinson's disease and hypertension
- Solid appearance
- White to off-white color
- Soluble in H2O at 100 mg/mL
Medchemexpress LLC 4-Aminobenzoic acid potassium | 138-84-1 | 99.8% | 100 G
4-Aminobenzoic acid potassium is a modifier of catecholamine oxidation reactions. It is promising for research of Parkinson's disease and hypertension, and is intended for research use only.
- Modifier of catecholamine oxidation reactions
- Potential for research in Parkinson's disease and hypertension
- Solid appearance, white to off-white in color
- Solubility in water (100 mg/mL, requires ultrasonic)
Medchemexpress LLC 4-Aminobenzoic acid potassium | 138-84-1 | MFCD00064911 | 99.96% | 5 G
4-Aminobenzoic acid potassium, also known as PABA potassium, is recognized as a modifier of catecholamine oxidation reactions. It shows promise for research related to Parkinson's disease and hypertension, functioning as both a microbial and human endogenous metabolite.
- Modifier of catecholamine oxidation reactions
- Promising for Parkinson's disease and hypertension research
- Target: microbial and human endogenous metabolite
- Appearance: solid
- Color: white to off-white
- Solubility: 100 mg/mL in H2O
Chemscene D-Luciferin (potassium) | 250mg | CS-7701 | 98% | 115144-35-9 | MFCD00044928 | 318 41 | C11H7KN2O3S2
Chemscene | D-Luciferin (potassium) | 250mg | CS-7701 | 98% | 115144-35-9 | MFCD00044928 | 318 41 | C11H7KN2O3S2
Chemscene D-Luciferin (potassium) | 1g | CS-7701 | 98% | 115144-35-9 | MFCD00044928 | 318 41 | C11H7KN2O3S2
Chemscene | D-Luciferin (potassium) | 1g | CS-7701 | 98% | 115144-35-9 | MFCD00044928 | 318 41 | C11H7KN2O3S2
Chemscene Potassium 4-Pyridyltrifluoroborate | 25g | CS-W010743 | 98% | 1111732-87-6 | MFCD09038543 | 185 00 | C5H4BF3KN
Chemscene | Potassium 4-Pyridyltrifluoroborate | 25g | CS-W010743 | 98% | 1111732-87-6 | MFCD09038543 | 185 00 | C5H4BF3KN
Chemscene Potassium 4-Pyridyltrifluoroborate | 5g | CS-W010743 | 98% | 1111732-87-6 | MFCD09038543 | 185 00 | C5H4BF3KN
Chemscene | Potassium 4-Pyridyltrifluoroborate | 5g | CS-W010743 | 98% | 1111732-87-6 | MFCD09038543 | 185 00 | C5H4BF3KN
Chemscene Potassium osmate dihydrate | 250mg | CS-0015987 | 99 9% | 10022-66-9 | MFCD00149919 | 368 45 | K2OsO4 2H2O
Chemscene | Potassium osmate dihydrate | 250mg | CS-0015987 | 99 9% | 10022-66-9 | MFCD00149919 | 368 45 | K2OsO4 2H2O
Chemscene Potassium osmate dihydrate | 1g | CS-0015987 | 99 9% | 10022-66-9 | MFCD00149919 | 368 45 | K2OsO4 2H2O
Chemscene | Potassium osmate dihydrate | 1g | CS-0015987 | 99 9% | 10022-66-9 | MFCD00149919 | 368 45 | K2OsO4 2H2O
Medchemexpress LLC (2,4-Dimethyl-6-morpholin-4-yl-pyridin-3-yl)-carbamic acid benzyl ester | 908608-06-0 | 341.40 | 25 MG
Potassium Channel Activator 1 is a potassium channel activator that can be used for the study of diseases or symptoms of dopaminergic system disorders.
- Acts as a potassium channel activator
- Useful for studying diseases or symptoms of dopaminergic system disorders
Medchemexpress LLC (2,4-Dimethyl-6-morpholin-4-yl-pyridin-3-yl)-carbamic acid benzyl ester | 908608-06-0 | 341.40 | 10 MG
Potassium Channel Activator 1 is a potassium channel activator. It can be used for the study of diseases or symptoms of dopaminergic system disorders.
- Potassium channel activator
- Used for the study of diseases or symptoms of dopaminergic system disorders
- 1
- 2